Dr. Pathak brings a depth of leadership experience to FGH BioTech to advance its first-in-class preclinical development candidate against aggressive cancers. With Dushyant' s leadership, FGH will ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback